Skip To Main Content

Life Sciences

Line chart indicating a rising trend
  • Home 
  • Life Sciences

Similar to the approach used to identify fund managers in the Cleantech Equity Fund Initiative, OCGC undertook the establishment of one or more limited partnerships focused on equity investments in life sciences technologies in which OCGC would participate on the same terms as the other limited partners.

With a prospective anchor commitment of up to $50 million, OCGC issued a call for expressions of interest from qualified managers to establish a new life sciences venture capital fund or from those managers that have an existing fund which has commenced fundraising but has not yet achieved a final close.

The fund(s) would primarily focus on investing capital to high potential, innovative Ontario-based life science companies. It is anticipated that OCGC's prospective investment commitment would leverage significant additional capital commitments from other investors.

Funds selected through the Life Science Venture Capital Fund Initiative

Lumira Ventures III L.P.

Genesys Ventures III L.P.

Amplitude Ventures Fund I L.P